Pacific Biosciences of California, Inc.
PACB
$1.33
$0.064.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -76.34% | -27.75% | -31.46% | -121.54% | -1.02% |
| Total Depreciation and Amortization | 624.28% | 625.89% | 830.60% | 1,116.84% | 101.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.32% | -110.49% | -107.96% | 35.91% | 13.80% |
| Change in Net Operating Assets | 110.95% | 109.38% | 70.85% | 57.22% | 31.17% |
| Cash from Operations | 46.03% | 47.29% | 40.82% | 27.37% | 20.49% |
| Capital Expenditure | 56.14% | 47.38% | 66.28% | 58.92% | 30.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.24% | 2,511.94% | -31.83% | 297.27% | 860.90% |
| Cash from Investing | -6.90% | 18,351.79% | -30.50% | 372.73% | 2,593.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -5,268.98% | -3,432.72% | -2,803.81% | -2,651.90% |
| Issuance of Common Stock | -55.50% | -60.32% | -77.63% | -81.50% | -96.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 107.97% | 37.13% | 37.58% | 40.93% | -139.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.13% | 92.89% | 59.03% | 93.29% | 14.17% |